SEARCH

SEARCH BY CITATION

References

  • Abdo H., Derkinderen P., Gomes P., Chevalier J., Aubert P., Masson D., Galmiche J. P., Vanden Berghe P., Neunlist M. and Lardeux B. (2010) Enteric glial cells protect neurons from oxidative stress in part via reduced glutathione. Faseb J. 24, 10821094.
  • Alessi D. R., Cuenda A., Cohen P., Dudley D. T. and Saltiel A. R. (1995) PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270, 2748927494.
  • Becker C., Jick S. S. and Meier C. R. (2008) Use of antihypertensives and the risk of Parkinson disease. Neurology 70, 14381444.
  • Braak H., De Vos R. A., Bohl J. and Del Tredici K. (2006) Gastric alpha-synuclein immunoreactive inclusions in Meissner’s and Auerbach’s plexuses in cases staged for Parkinson’s disease-related brain pathology. Neurosci. Lett. 396, 6772.
  • Braak H., Del Tredici K., Rub U., De Vos R. A., Jansen Steur E. N. and Braak E. (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol. Aging 24, 197211.
  • Camilleri M., Cowen T. and Koch T. R. (2008) Enteric neurodegeneration in ageing. Neurogastroenterol. Motil. 20, 185196.
  • Carballo-Carbajal I., Weber-Endress S., Rovelli G., Chan D., Wolozin B., Klein C. L., Patenge N., Gasser T. and Kahle P. J. (2010) Leucine-rich repeat kinase 2 induces alpha-synuclein expression via the extracellular signal-regulated kinase pathway. Cell. Signal. 22, 821827.
  • Catterall W. A. (2000) Structure and regulation of voltage-gated Ca2+ channels. Cell. Annu. Rev. Biol. Dev. 16, 521555.
  • Chan C. S., Guzman J. N., Ilijic E., Mercer J. N., Rick C., Tkatch T., Meredith G. E. and Surmeier D. J. (2007) ‘Rejuvenation’ protects neurons in mouse models of Parkinson’s disease. Nature 447, 10811086.
  • Chartier-Harlin M. C., Kachergus J., Roumier C., Mouroux V., Douay X., Lincoln S., Levecque C., Larvor L., Andrieux J., Hulihan M., Waucquier N., Defebvre L., Amouyel P., Farrer M. and Destee A. (2004) Alpha-synuclein locus duplication as a cause of familial Parkinson’s disease. Lancet 364, 11671169.
  • Chesselet M. F. (2008) In vivo alpha-synuclein overexpression in rodents: a useful model of Parkinson’s disease? Exp. Neurol. 209, 2227.
  • Chevalier J., Derkinderen P., Gomes P., Thinard R., Naveilhan P., Vanden Berghe P. and Neunlist M. (2008) Activity-dependent regulation of tyrosine hydroxylase expression in the enteric nervous system. J. Physiol. 586, 19631975.
  • Chijiwa T., Mishima A., Hagiwara M., Sano M., Hayashi K., Inoue T., Naito K., Toshioka T. and Hidaka H. (1990) Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. J. Biol. Chem. 265, 52675272.
  • Cigola E., Volpe B. T., Lee J. W., Franzen L. and Baker H. (1998) Tyrosine hydroxylase expression in primary cultures of olfactory bulb: role of L-type calcium channels. J. Neurosci. 18, 76387649.
  • Clough R. L. and Stefanis L. (2007) A novel pathway for transcriptional regulation of alpha-synuclein. Faseb J. 21, 596607.
  • Derkinderen P., Enslen H. and Girault J. A. (1999) The ERK/MAP-kinases cascade in the nervous system. Neuroreport 10, R2434.
  • Desplats P., Lee H. J., Bae E. J., Patrick C., Rockenstein E., Crews L., Spencer B., Masliah E. and Lee S. J. (2009) Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc. Natl Acad. Sci. U.S.A. 106, 1301013015.
  • Favata M. F., Horiuchi K. Y., Manos E. J., Daulerio A. J., Stradley D. A., Feeser W. S., Van Dyk D. E., Pitts W. J., Earl R. A., Hobbs F., Copeland R. A., Magolda R. L., Scherle P. A. and Trzaskos J. M. (1998) Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273, 1862318632.
  • Flavell S. W. and Greenberg M. E. (2008) Signaling mechanisms linking neuronal activity to gene expression and plasticity of the nervous system. Annu. Rev. Neurosci. 31, 563590.
  • Gomez-Santos C., Ferrer I., Santidrian A. F., Barrachina M., Gil J. and Ambrosio S. (2003) Dopamine induces autophagic cell death and alpha-synuclein increase in human neuroblastoma SH-SY5Y cells. J. Neurosci. Res. 73, 341350.
  • Grewal S. S., York R. D. and Stork P. J. (1999) Extracellular-signal-regulated kinase signalling in neurons. Curr. Opin. Neurobiol. 9, 544553.
  • Grewal S. S., Horgan A. M., York R. D., Withers G. S., Banker G. A. and Stork P. J. (2000) Neuronal calcium activates a Rap1 and B-Raf signaling pathway via the cyclic adenosine monophosphate-dependent protein kinase. J. Biol. Chem. 275, 37223728.
  • Howe D. G., Clarke C. M., Yan H., Willis B. S., Schneider D. A., McKnight G. S. and Kapur R. P. (2006) Inhibition of protein kinase A in murine enteric neurons causes lethal intestinal pseudo-obstruction. J. Neurobiol. 66, 256272.
  • Jinnah H. A., Yitta S., Drew T., Kim B. S., Visser J. E. and Rothstein J. D. (1999) Calcium channel activation and self-biting in mice. Proc. Natl Acad. Sci. U.S.A. 96, 1522815232.
  • Konradi C., Macias W., Dudman J. T. and Carlson R. R. (2003) Striatal proenkephalin gene induction: coordinated regulation by cyclic AMP and calcium pathways. Brain Res. 115, 157161.
  • Kulich S. M. and Chu C. T. (2001) Sustained extracellular signal-regulated kinase activation by 6-hydroxydopamine: implications for Parkinson’s disease. J. Neurochem. 77, 10581066.
  • Lebouvier T., Chaumette T., Paillusson S., Duyckaerts C., Bruley des Varannes S., Neunlist M. and Derkinderen P. (2009) The second brain and Parkinson’s disease. Eur. J. Neurosci. 30, 735741.
  • Lebouvier T., Chaumette T., Damier P., Coron E., Touchefeu Y., Vrignaud S., Naveilhan P., Galmiche J. P., Bruley des Varannes S., Derkinderen P. and Neunlist M. (2008) Pathological lesions in colonic biopsies during Parkinson’s disease. Gut 57, 17411743.
  • Lee H. J., Patel S. and Lee S. J. (2005) Intravesicular localization and exocytosis of alpha-synuclein and its aggregates. J. Neurosci. 25, 60166024.
  • Lerner E. C., Qian Y., Blaskovich M. A., Fossum R. D., Vogt A., Sun J., Cox A. D., Der C. J., Hamilton A. D. and Sebti S. M. (1995) Ras CAAX peptidomimetic FTI-277 selectively blocks oncogenic Ras signaling by inducing cytoplasmic accumulation of inactive Ras-Raf complexes. J. Biol. Chem. 270, 2680226806.
  • Livak K. J. and Schmittgen T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (San Diego, CA) 25, 402408.
  • Melis M., Camarini R., Ungless M. A. and Bonci A. (2002) Long-lasting potentiation of GABAergic synapses in dopamine neurons after a single in vivo ethanol exposure. J. Neurosci. 22, 20742082.
  • Neylon C. B., Fowler C. J. and Furness J. B. (2006) Regulation of the slow afterhyperpolarization in enteric neurons by protein kinase A. Auton. Neurosci. 126–127, 258263.
  • Obara Y., Horgan A. M. and Stork P. J. (2007) The requirement of Ras and Rap1 for the activation of ERKs by cAMP, PACAP, and KCl in cerebellar granule cells. J. Neurochem. 101, 470482.
  • Phillips R. J., Pairitz J. C. and Powley T. L. (2007) Age-related neuronal loss in the submucosal plexus of the colon of Fischer 344 rats. Neurobiol. Aging 28, 11241137.
  • Phillips R. J., Walter G. C., Wilder S. L., Baronowsky E. A. and Powley T. L. (2008) Alpha-synuclein-immunopositive myenteric neurons and vagal preganglionic terminals: autonomic pathway implicated in Parkinson’s disease? Neuroscience 153, 733750.
  • Phillips R. J., Walter G. C., Ringer B. E., Higgs K. M. and Powley T. L. (2009) Alpha-synuclein immunopositive aggregates in the myenteric plexus of the aging Fischer 344 rat. Exp. Neurol. 220, 109119.
  • Ramnath R. R., Strange K. and Rosenberg P. A. (1992) Neuronal injury evoked by depolarizing agents in rat cortical cultures. Neuroscience 51, 931939.
  • Scherzer C. R., Grass J. A., Liao Z., Pepivani I., Zheng B., Eklund A. C., Ney P. A., Ng J., McGoldrick M., Mollenhauer B., Bresnick E. H. and Schlossmacher M. G. (2008) GATA transcription factors directly regulate the Parkinson’s disease-linked gene alpha-synuclein. Proc. Natl Acad. Sci. U.S.A. 105, 1090710912.
  • Shyu W. C., Lin S. Z., Saeki K., Kubosaki A., Matsumoto Y., Onodera T., Chiang M. F., Thajeb P. and Li H. (2004) Hyperbaric oxygen enhances the expression of prion protein and heat shock protein 70 in a mouse neuroblastoma cell line. Cell. Mol. Neurobiol. 24, 257268.
  • Singleton A. B., Farrer M., Johnson J., Singleton A., Hague S., Kachergus J., Hulihan M., Peuralinna T., Dutra A., Nussbaum R., Lincoln S., Crawley A., Hanson M., Maraganore D., Adler C., Cookson M. R., Muenter M., Baptista M., Miller D., Blancato J., Hardy J. and Gwinn-Hardy K. (2003) Alpha-synuclein locus triplication causes Parkinson’s disease. Science 302, 841.
  • Smith T. K., Kang S. H. and Vanden Berghe P. (2003) Calcium channels in enteric neurons. Curr. Opin. Pharmacol. 3, 588593.
  • Spillantini M. G., Schmidt M. L., Lee V. M., Trojanowski J. Q., Jakes R. and Goedert M. (1997) Alpha-synuclein in Lewy bodies. Nature 388, 839840.
  • Stefanis L., Kholodilov N., Rideout H. J., Burke R. E. and Greene L. A. (2001) Synuclein-1 is selectively up-regulated in response to nerve growth factor treatment in PC12 cells. J. Neurochem. 76, 11651176.
  • Sung J. Y., Kim J., Paik S. R., Park J. H., Ahn Y. S. and Chung K. C. (2001) Induction of neuronal cell death by Rab5A-dependent endocytosis of alpha-synuclein. J. Biol. Chem. 276, 2744127448.
  • Waxman E. A. and Giasson B. I. (2009) Molecular mechanisms of alpha-synuclein neurodegeneration. Biochim. Biophys. Acta 1792, 616624.
  • Zhu J. H., Kulich S. M., Oury T. D. and Chu C. T. (2002) Cytoplasmic aggregates of phosphorylated extracellular signal-regulated protein kinases in Lewy body diseases. Am. J. Pathol. 161, 20872098.